Delivery Order SPE2DB20D2014-SPE2DB24FB03Z
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $45,192.37 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide GEMTESA 75 MG TABLET 90S, a prescription pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a potential value of $1,668.98. The contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) with DLA that has a potential value...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,338.47 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GEMTESA 75 MG TABLET 90S. This delivery order has a completion date of February 13, 2024 and was awarded on February 12, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order contract by the Defense Logistics Agency Troop Support Medical valued at $2,522.08. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to support military treatment programs and facilities. This award is associated with a larger Indefinite Delivery Contract (IDC) with a potential value up to $999,999,999.00 that allows Amerisourcebergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The $7,572.53 contract has an ultimate completion date of November 24, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,416.72 firm fixed-price delivery order is for GEMTESA 75 MG TABLET 90S, with an ultimate completion date of April 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,042.86 firm-fixed-price delivery order is for 4565123420 GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a $5,043.93 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a performance period through November 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,518.30, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $16,491.74. This firm fixed-price delivery order, which is due for completion by July 22, 2025, represents a pharmaceutical supply requirement under DLA's medical procurement operations. The award was competitively awarded with no set-aside designation, and AmerisourceBergen will perform the work at its...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB03ZDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $17,324.71 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of February 9, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 2/8/24 |